Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avid Radiopharmaceuticals
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmatory cohort subjects who completed the 18F-AV-1451-A05 (NCT02016560) study
You may not be if
Current clinically significant cardiovascular disease, ECG abnormalities, risk factors for Torsades de Pointes (TdP), or are taking drugs known to cause QT prolongation
Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer
Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception
Have had a non-study related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session
Have received or participated in a trial with investigational medications in the past 30 days
Clareo Health | Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
